Esperion Therapeutics
ESPR
#6169
Rank
โ‚น79.43 B
Marketcap
โ‚น335.09
Share price
-1.58%
Change (1 day)
18.47%
Change (1 year)

Esperion Therapeutics (ESPR) - Total assets

Total assets on the balance sheet as of September 2025 : โ‚น32.70 Billion

According to Esperion Therapeutics's latest financial reports the company's total assets are โ‚น32.70 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Esperion Therapeutics - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2024-12-31โ‚น29.49 B72.16%
2023-12-31โ‚น17.13 B-16.5%
2022-12-31โ‚น20.51 B-27.76%
2021-12-31โ‚น28.40 B9.94%
2020-12-31โ‚น25.83 B68.94%
2019-12-31โ‚น15.29 B52.46%
2018-12-31โ‚น10.03 B-43.46%
2017-12-31โ‚น17.73 B6.46%
2016-12-31โ‚น16.66 B-15.17%
2015-12-31โ‚น19.64 B116.31%
2014-12-31โ‚น9.08 B87.73%
2013-12-31โ‚น4.83 B1108.11%
2012-12-31โ‚น0.40 B247.22%
2011-12-31โ‚น0.11 B
2002-12-31โ‚น2.46 B-34.78%
2001-12-31โ‚น3.78 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Ultragenyx Pharmaceutical
RARE
โ‚น106.94 B 227.03%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚น684.09 B 1,991.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น18.751 T 57,240.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
โ‚น3.608 T 10,934.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
โ‚น78.05 B 138.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
โ‚น18.49 B-43.43%๐Ÿ‡บ๐Ÿ‡ธ USA